CSL

CSL is a global specialty biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. We produce safe and effective therapies for patients who rely on them for their quality of life and sometimes for life itself, enabling many thousands of people around the world to lead normal healthy lives.

CSL employs over 13,000 staff in more than 27 countries. Our headquarters are in Australia and we have substantial manufacturing operations in the US, Germany, Switzerland and Australia. CSL also has one of the largest plasma collections networks in the world and operates the only influenza vaccine manufacturing facility in the Southern Hemisphere.

For more information please visit www.csl.com.au